Chanitra Thuwajit

3.5k total citations · 1 hit paper
53 papers, 2.6k citations indexed

About

Chanitra Thuwajit is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Chanitra Thuwajit has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 21 papers in Molecular Biology and 18 papers in Immunology. Recurrent topics in Chanitra Thuwajit's work include Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Immunotherapy and Immune Responses (9 papers) and CAR-T cell therapy research (8 papers). Chanitra Thuwajit is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Immunotherapy and Immune Responses (9 papers) and CAR-T cell therapy research (8 papers). Chanitra Thuwajit collaborates with scholars based in Thailand, Japan and United Kingdom. Chanitra Thuwajit's co-authors include Peti Thuwajit, Marcela A. Hermoso, Marjorie De la Fuente, Glauben Landskron, Siri Chau‐in, Suyanee Thongchot, Kusumawadee Utispan, Malee Warnnissorn, Pa‐thai Yenchitsomanus and Pornchai O‐charoenrat and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Chanitra Thuwajit

52 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic Inflammation and Cytokines in the Tumor Microenvironment

2014 1.4k citations Peti Thuwajit, Chanitra Thuwajit et al. profile →

Peers

Countries citing papers authored by Chanitra Thuwajit

Since Specialization

Citations

This map shows the geographic impact of Chanitra Thuwajit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chanitra Thuwajit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chanitra Thuwajit more than expected).

Fields of papers citing papers by Chanitra Thuwajit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chanitra Thuwajit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chanitra Thuwajit. The network helps show where Chanitra Thuwajit may publish in the future.

Co-authorship network of co-authors of Chanitra Thuwajit

This figure shows the co-authorship network connecting the top 25 collaborators of Chanitra Thuwajit. A scholar is included among the top collaborators of Chanitra Thuwajit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chanitra Thuwajit. Chanitra Thuwajit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SynProtX: a large-scale proteomics-based deep learning model for predicting synergistic anticancer drug combinations 2025 ·GigaScience ·(unknown), (unknown), (unknown), (unknown), Chanitra Thuwajit, Thanyada Rungrotmongkol, Sarana Nutanong	1
2	Hippo pathway in cancer cells induces NCAM1+αSMA+ fibroblasts to modulate tumor microenvironment 2024 ·Communications Biology ·(unknown), Yasuhisa Sakamoto, (unknown), (unknown), Suyanee Thongchot, (unknown), (unknown), (unknown), Somponnat Sampattavanich, (unknown), (unknown), (unknown), (unknown), Yohei Kanamori, Peti Thuwajit, Keiichi I. Nakayama, Kun‐Liang Guan, Yorifumi Satou, Chanitra Thuwajit, Toshiro Moroishi	4
3	The combined tumour-based Fascin/Snail and stromal periostin reveals the effective prognosis prediction in colorectal cancer patients 2024 ·PLoS ONE ·(unknown), Suyanee Thongchot, Ananya Pongpaibul, Atthaphorn Trakarnsanga, Jean A. Quinn, Peti Thuwajit, Chanitra Thuwajit, Joanne Edwards	1
4	Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer 2024 ·The Journal of Pathology Clinical Research ·(unknown), Kathryn A.F. Pennel, (unknown), (unknown), Antonia K. Roseweir, (unknown), Jennifer Hay, Ditte K. Andersen, Noori Maka, James O. Park, Campbell S.D. Roxburgh, Chanitra Thuwajit, Donald McMillan, Joanne Edwards	1
5	Detection of centroblast cells in H&E stained whole slide image based on object detection 2024 ·Frontiers in Medicine ·(unknown), Paisarn Boonsakan, (unknown), Peti Thuwajit, Komgrid Charngkaew, Ananya Pongpaibul, Napat Angkathunyakul, Narit Hnoohom, Chanitra Thuwajit	0
6	Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways 2023 ·Breast Cancer Research ·(unknown), (unknown), (unknown), (unknown), Suyanee Thongchot, Mutita Junking, Peti Thuwajit, Pa‐thai Yenchitsomanus, Chanitra Thuwajit	37
7	Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review) 2023 ·International Journal of Molecular Medicine ·Suyanee Thongchot, (unknown), Peti Thuwajit, Pa‐thai Yenchitsomanus, Chanitra Thuwajit	23
8	Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer 2022 ·Molecular Cancer Therapeutics ·Suyanee Thongchot, (unknown), (unknown), (unknown), (unknown), (unknown), Pornchai O‐charoenrat, Peti Thuwajit, Pa‐thai Yenchitsomanus, Chanitra Thuwajit	18
9	HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells 2022 ·BMC Cancer ·(unknown), Suyanee Thongchot, (unknown), Carol Box, Somaieh Hedayat, Peti Thuwajit, Suzanne A. Eccles, Chanitra Thuwajit	36
10	Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer 2021 ·BMC Cancer ·(unknown), (unknown), (unknown), Suyanee Thongchot, Chalermchai Mitrpant, Pornchai O‐charoenrat, Chanitra Thuwajit, Peti Thuwajit	22
11	Intracellular IL-33 Attenuates Extracellular IL-33-induced Cholangiocarcinoma Cell Proliferation and InvasionviaNF-κB and GSK-3β Pathways 2021 ·Anticancer Research ·(unknown), Suyanee Thongchot, Kulthida Vaeteewoottacharn, Peti Thuwajit, Marcela A. Hermoso, Seiji Okada, Chanitra Thuwajit	4
12	High level of interleukin-33 in cancer cells and cancer-associated fibroblasts correlates with good prognosis and suppressed migration in cholangiocarcinoma 2020 ·Journal of Cancer ·(unknown), Suyanee Thongchot, Ananya Pongpaibul, Kulthida Vaeteewoottacharn, Somchai Pinlaor, Peti Thuwajit, Seiji Okada, Chanitra Thuwajit	16
13	Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells 2018 ·Cancer Cell International ·(unknown), Chanitra Thuwajit, Komgrid Charngkaew, Peti Thuwajit	18
14	Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis 2017 ·Oncology Letters ·Chanitra Thuwajit, Peti Thuwajit, (unknown), Chawalit Pairojkul, Sopit Wongkham, Vajarabhongsa Bhudhisawasdi, Junya Ono, Shoichiro Ohta, Kiminori Fujimoto, Kenji Izuhara	20
15	Pyruvate Carboxylase Is Up-Regulated in Breast Cancer and Essential to Support Growth and Invasion of MDA-MB-231 Cells 2015 ·PLoS ONE ·(unknown), Chanitra Thuwajit, Malee Warnnissorn, John C. Wallace, Michael J. MacDonald, Sarawut Jitrapakdee	85
16	Periostin activates integrin α5β1 through a PI3K/AKT-dependent pathway in invasion of cholangiocarcinoma 2012 ·International Journal of Oncology ·Kusumawadee Utispan, (unknown), Peti Thuwajit, Siri Chau‐in, Chawalit Pairojkul, Sopit Wongkham, Chanitra Thuwajit	83
17	Estrogen is increased in male cholangiocarcinoma patients’ serum and stimulates invasion in cholangiocarcinoma cell lines in vitro 2012 ·Journal of Cancer Research and Clinical Oncology ·Taweewun Hunsawong, (unknown), (unknown), (unknown), Chanitra Thuwajit, Banchob Sripa, Anucha Paupairoj, Siri Chau‐in, Peti Thuwajit	28
18	Secreted Opisthorchis viverrini glutathione S-transferase regulates cell proliferation through AKT and ERK pathways in cholangiocarcinoma 2011 ·Parasitology International ·(unknown), Peti Thuwajit, (unknown), Thewarach Laha, Sasithorn Kaewkes, Yaeta Endo, Chanitra Thuwajit	18
19	Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival 2008 ·Journal of Gastroenterology and Hepatology ·Peti Thuwajit, (unknown), Chanitra Thuwajit, Banchob Sripa, Anucha Paupairoj, Siri Chau‐in	18
20	Increased cell proliferation of mouse fibroblast NIH-3T3 in vitro induced by excretory/secretory product(s) from Opisthorchis viverrini 2004 ·Parasitology ·Chanitra Thuwajit, Peti Thuwajit, Sasithorn Kaewkes, Banchob Sripa, Kazushige Uchida, Masanao Miwa, Sopit Wongkham	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact